Authors: DeNardo, SJ Burke, PA Leigh, BR O'Donnell, RT Miers, LA Kroger, LA Goodman, SL Matzku, S Jonczyk, A Lamborn, KR DeNardo, GL

Citation: Sj. Denardo et al., Neovascular targeting with cyclic RGD peptide (cRGDf-ACHA) to enhance delivery of radioimmunotherapy, CANC BIO R, 15(1), 2000, pp. 71-79

Authors: Leigh, BR Burke, PA Hong, AM O'Donnell, RT Howell, LP Miers, LA DeNardo, GL DeNardo, SJ

Citation: Br. Leigh et al., Preclinical evaluation of chimeric L6 antibody for the treatment of Kaposi's sarcoma with radioimmunotherapy, CANC BIO R, 14(2), 1999, pp. 113-119

Authors: O'Donnell, RT DeNardo, SJ Miers, LA Kukis, DL Mirick, GR Kroger, LA DeNardo, GL

Citation: Rt. O'Donnell et al., Combined modality radioimmunotherapy with taxol and Y-90-LYM-1 for Raji lymphoma xenografts, CANC BIO R, 13(5), 1998, pp. 351-361

Authors: Denardo, SJ Richman, CM Kukis, DL Shen, S Lamborn, KR Miers, LA Kroger, LA Perez, EA DeNardo, GL

Citation: Sj. Denardo et al., Synergistic therapy of breast cancer with Y-90-chimeric L6 and paclitaxel in the xenografted mouse model: Development of a clinical protocol, ANTICANC R, 18(6A), 1998, pp. 4011-4018